Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D)

Clinical and Experimental Nephrology

Volumn 14, Issue 4, 2010, Pages 340-348

  Tajima, Reiko ^a   Kondo, Masahide ^a   Kai, Hirayasu ^a   Saito, Chie ^a   Okada, Masafumi ^a   Takahashi, Hideto ^a   Doi, Mariko ^a   Tsuruoka, Shuichi ^a   Yamagata, Kunihiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Chronic kidney disease (CKD); EuroQol (EQ 5D); Health related quality of life (HRQOL); Quality adjustment weight

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; ECONOMIC EVALUATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; WEIGHT REDUCTION;

ADULT; AGED; ANALYSIS OF VARIANCE; ANEMIA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; JAPAN; KIDNEY DISEASES; MALE; MALNUTRITION; MIDDLE AGED; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 78649479397     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0304-1     Document Type: Article

References (27)

1. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, classification, and stratification. Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease. Am J Kidney Dis. 2002;39:76-110.
2. Levey AS, Eckardt KW, Tsukamoto Y, Levin A, Coresh J. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089-100.
3. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic kidney disease CKD in Japanese general population. Clin Exp Nephrol. 2009;13:621-30.
4. Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan as of Dec 31, 2008. Tokyo: Japanese Society for Dialysis Treatment; 2009 (in Japanese).
5. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med. 2001;134:629-36.
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-305.
7. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102:203-10.
8. Brugts JJ,KnetschAM,Mattace-Raso FU,Hofman A,Witteman JC. Renal function and risk of myocardial infarction in an elderly population: The Rotterdam Study. Arch InternMed. 2005;165:2659-65.
9. Gold RM, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
10. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
11. Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, Eisele G, Burrows-Hudson S, et al. Quality of life in chronic kidney disease (CKD): A cross-sectional analysis in the Renal Research Institute- CKD Study. Am J Kidney Dis. 2005;45:658-66.
12. Leaf DE, Goldfarb DS. Interpretation and review of health-related quality of life in CKD patients receiving treatment for anemia. Kidney Int. 2009;75:15-24.
13. Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007.
14. Japanese EuroQol Translation Team. The development of the Japanese EuroQol instrument. J Health Care Soc. 1997;8:109-23. (in Japanese).
15. Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: The case of Japan. Health Econ. 2002;11:341-53.
16. Matsuo S, Imai E, Horino M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-92.
17. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74:829-36.
18. Gorodetskaya I, Zenion S, McCulloch CE, Bostrom A, Hsu CY, Bindman AB, et al. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int. 2005;68:2801-8.
19. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The health utilities index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33:375-84.
20. Dale PL, Hutton J, Elgazzar H. Utility of health states in chronic kidney disease: A structured review of the literature. Curr Med Res Opin. 2008;24:193-206.
21. de Wit GA, Ramsteijn PG, de Charro FT. Economic evaluation of end stage renal disease treatment. Health Policy. 1998;44:215-32.
22. Greiner W, Obermann K, Schulenburg JM. Socio-economic evaluation of kidney transplantation in Germany. Arch Hell Med. 2001;18:147-55.
23. Manns B, Johnson JA, TaubK,Mortis G,Donaldson GC. Quality of life in patients treatedwith haemodialysis or peritoneal dialysis:what are the important determinants? Clin Nephrol. 2003;60:341-51.
24. Sennfält K, Magnusson M, Carlsson P. Comparison of haemodialysis and peritoneal dialysis-a cost-utility analysis. Perit Dial Int. 2002;22:39-47.
25. Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa. Curr Med Res Opin. 2006;22:1929-37. (Pubitemid 44663398)
26. Japanese Society of Nephrology. Clinical practice guidebook for diagnosis and treatment of chronic kidney disease. Tokyo: Igakusha; 2007 (in Japanese).
27. Sakamaki H, Ikeda S, Ikegami N, Uchigata Y, Iwamoto Y, Origasa H, et al. Measurement of HRQL using EQ-5D in patients with Type 2 diabetes mellitus in Japan. Value Health. 2006;9:47-53.